Delivery Order SPE2DB22D3401-SPE2DB25FT2NY

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.07 firm fixed-price delivery order is for KETOROLAC 30 MG/ML VIALML, a generic pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the...
This federal contract award, valued at $13,548.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (no set-aside designation) for the supply of Ketorolac 30 mg/mL vials. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,909.40, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical worth up to $999,999,999 through November 2026. The specific contract covers the supply of 4567520455 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4566698091 KETOROLAC 15 MG/ML vials. The firm-fixed-price contract has a ceiling value of $4,639.86 and an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.84 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a pain medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.61, is a Delivery Order for the supply of 4565067877 - Ketorolac 60 mg/2 ml vials. The contract has an ultimate completion date of July 5, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,190.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Ketorolac 30 mg/mL vials, a medication used for pain management. The contract is a firm fixed-price delivery order with a completion date of November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,879.12, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This award is for the supply of 4567060543 - Ketorolac 30 mg/ml vials, a pain management medication. The contract has no set-aside...
This federal contract award, valued at $2,249.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. There was no set-aside designation for this award. Amerisourcebergen holds a...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2NY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $1,819.97 and is a Delivery Order type with a Firm Fixed Price pricing structure. It covers the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, with a period of performance through March 11, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 6/9/25, 9:56 AM